Professor James Jarrett

  • Honorary Senior Research Fellow (School of Biodiversity, One Health & Veterinary Medicine)

Publications

List by: Type | Date

Jump to: 2002 | 2000 | 1999 | 1998 | 1997 | 1996
Number of items: 12.

2002

Dunham, S.P. et al. (2002) Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and-18. Vaccine, 20, pp. 1483-1496. (doi: 10.1016/S0264-410X(01)00507-2)

Hosie, M.J. , Willett, B.J. , Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., Neil, J.C. and Jarrett, O. (2002) Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. Journal of Virology, 76(12), pp. 6062-6072. (doi: 10.1128/JVI.76.12.6062-6072.2002)

2000

Hosie, M.J. et al. (2000) Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. Journal of Virology, 74(20), pp. 9403-9411. (doi: 10.1128/JVI.74.20.9403-9411.2000)

Flynn, J.N., Hosie, M.J. , Rigby, M.A., Mackay, N., Cannon, C.A., Dunsford, T., Neil, J.C. and Jarrett, O. (2000) Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination. Vaccine, 18(11-12), pp. 1118-1132. (doi: 10.1016/S0264-410X(99)00375-8) (PMID:10590334)

1999

Flynn, J.N., Cannon, C.A., Sloan, D., Neil, J.C. and Jarrett, O. (1999) Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes. Immunology, 96(2), pp. 220-229. (PMID:10233699) (PMCID:PMC2326736)

1998

Hosie, M.J. et al. (1998) DNA vaccination affords significant protection against feline immunodeficiency virus without inducing detectable antiviral antibodies. Journal of Virology, 72(9), pp. 7310-7319.

Ramsey, I.K. , Spibey, N. and Jarrett, O. (1998) The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization. Journal of Virology, 72(4), (PMID:9525654) (PMCID:PMC109800)

Beatty, J.A., Lawrence, C.E., Callanan, J.J., Grant, C.K., Gault, E.A., Neil, J.C. and Jarrett, O. (1998) Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis. Veterinary Immunology and Immunopathology, 65(2-4), pp. 309-322. (doi: 10.1016/S0165-2427(98)00164-0) (PMID:9839882)

1997

Flynn, J.N., Cannon, C.A., Neil, J.C. and Jarrett, O. (1997) Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection. Journal of Virology, 71(10), pp. 7586-7592. (PMCID:PMC192106)

Rigby, M.A., Hosie, M.J., Willett, B.J., Mackay, N., McDonald, M., Cannon, C., Dunsford, T., Jarrett, O. and Neil, J.C. (1997) Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Research and Human Retroviruses, 13(5), pp. 405-12. (doi: 10.1089/aid.1997.13.405) (PMID:9075482)

1996

Flynn, J.N., Keating, P., Hosie, M.J. , Mackett, M., Stephens, E.B., Beatty, J.A., Neil, J.C. and Jarrett, O. (1996) Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. Journal of Immunology, 157(8), pp. 3658-65. (PMID:8871667)

Rigby, M.A., Mackay, N., Reid, G., Osborne, R., Neil, J.C. and Jarrett, O. (1996) Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. Vaccine, 14(12), pp. 1095-1102. (doi: 10.1016/0264-410X(96)00060-6) (PMID:8911003)

This list was generated on Wed Nov 29 09:25:35 2023 GMT.
Jump to: Articles
Number of items: 12.

Articles

Dunham, S.P. et al. (2002) Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and-18. Vaccine, 20, pp. 1483-1496. (doi: 10.1016/S0264-410X(01)00507-2)

Hosie, M.J. , Willett, B.J. , Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., Neil, J.C. and Jarrett, O. (2002) Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. Journal of Virology, 76(12), pp. 6062-6072. (doi: 10.1128/JVI.76.12.6062-6072.2002)

Hosie, M.J. et al. (2000) Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. Journal of Virology, 74(20), pp. 9403-9411. (doi: 10.1128/JVI.74.20.9403-9411.2000)

Flynn, J.N., Hosie, M.J. , Rigby, M.A., Mackay, N., Cannon, C.A., Dunsford, T., Neil, J.C. and Jarrett, O. (2000) Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination. Vaccine, 18(11-12), pp. 1118-1132. (doi: 10.1016/S0264-410X(99)00375-8) (PMID:10590334)

Flynn, J.N., Cannon, C.A., Sloan, D., Neil, J.C. and Jarrett, O. (1999) Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes. Immunology, 96(2), pp. 220-229. (PMID:10233699) (PMCID:PMC2326736)

Hosie, M.J. et al. (1998) DNA vaccination affords significant protection against feline immunodeficiency virus without inducing detectable antiviral antibodies. Journal of Virology, 72(9), pp. 7310-7319.

Ramsey, I.K. , Spibey, N. and Jarrett, O. (1998) The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization. Journal of Virology, 72(4), (PMID:9525654) (PMCID:PMC109800)

Beatty, J.A., Lawrence, C.E., Callanan, J.J., Grant, C.K., Gault, E.A., Neil, J.C. and Jarrett, O. (1998) Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis. Veterinary Immunology and Immunopathology, 65(2-4), pp. 309-322. (doi: 10.1016/S0165-2427(98)00164-0) (PMID:9839882)

Flynn, J.N., Cannon, C.A., Neil, J.C. and Jarrett, O. (1997) Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection. Journal of Virology, 71(10), pp. 7586-7592. (PMCID:PMC192106)

Rigby, M.A., Hosie, M.J., Willett, B.J., Mackay, N., McDonald, M., Cannon, C., Dunsford, T., Jarrett, O. and Neil, J.C. (1997) Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation. AIDS Research and Human Retroviruses, 13(5), pp. 405-12. (doi: 10.1089/aid.1997.13.405) (PMID:9075482)

Flynn, J.N., Keating, P., Hosie, M.J. , Mackett, M., Stephens, E.B., Beatty, J.A., Neil, J.C. and Jarrett, O. (1996) Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. Journal of Immunology, 157(8), pp. 3658-65. (PMID:8871667)

Rigby, M.A., Mackay, N., Reid, G., Osborne, R., Neil, J.C. and Jarrett, O. (1996) Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein. Vaccine, 14(12), pp. 1095-1102. (doi: 10.1016/0264-410X(96)00060-6) (PMID:8911003)

This list was generated on Wed Nov 29 09:25:35 2023 GMT.